Ravenscroft, Paula <br/><br/>
Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.  [electronic resource] 

 -  Experimental neurology  Jan 2004 
 - 36-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-4886 
<br/><br/><label>Standard No.: </label>10.1016/j.expneurol.2003.09.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Behavior, Animal--drug effects<br/>Corpus Striatum--drug effects<br/>Disease Models, Animal<br/>Dopamine Agonists--therapeutic use<br/>Dyskinesia, Drug-Induced--physiopathology<br/>Enkephalins--genetics<br/>Gene Expression--drug effects<br/>In Situ Hybridization<br/>Indoles--therapeutic use<br/>Levodopa--adverse effects<br/>Male<br/>Motor Activity--drug effects<br/>Opioid Peptides--genetics<br/>Oxidopamine<br/>Parkinsonian Disorders--chemically induced<br/>Protein Precursors--genetics<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Synaptic Transmission--drug effects